Cutera CTO steps down
Cutera (NSDQ:CUTR) (NSDQ:CUTR) announced the resignation of Leonard DeBenedictis, who is stepping down just 18-months after being named CTO of the Mountain View, Calif.-based aesthetic device maker.
DeBenedictis, who joined Cutera in January 2011, left the company to pursue "personal interests," according to regulatory filings. Prior to working with Cutera, DeBenedictis co-founded Solta Medical, Inc., which acquired Reliant Technologies in 2008.
The company also said in a separate filing that Michael Karavitis, will join the company as vice president of research & development.
Karavitis recently worked for LenSx (acquired by Alcon), Newport Corp. and Intralase Corp. (acquired by Advanced Medical Optics). He will succeed DeBenedictis, officials said in a prepared release.
"We are confident that with Michael’s leadership we will continue our history of introducing innovative solutions for the aesthetics market," president & CEO Kevin Connors said in prepared remarks. "In August 2012, we commenced shipments of our truSculpt product and we plan to continue investing in our research and development activities."
Read more
Natus Medical VP let go
Natus Medical’s (NSDQ:BABY) North American operations VP William Mince will leave the company after his position was eliminated in connection with "an internal restructuring plan." Natus expects that Mince will remain with the company until the end of the year.
Read more
DJO Global adds 2 board members
Medical device company DJO Global appointed James R. Lawson and James Quella as new directors to the board.
Lawson is currently chairman of Innovation Medical Device Solutions (IMDS). Quella is a senior managing director and senior operating partner in the corporate private equity group of The Blackstone Group.
Read more
Surefire Medical has new international business director
Colorado-based medical device maker Surefire Medical named Christopher Mennone its director of international business, tasking him with establishing an international presence.
Mennone was the director of international sales for Medivance, a medical device manufacturer that was recently acquired by C.R. Bard (NYSE:BCR).
Read more
InspireMD, Inc adds one board member
InspireMD (OTC:NSPR) appointed James Loughlin as a board member and the chairman of audit committee, effective September 21. Loughlin was previously the national director of the pharmaceuticals practice at KPMG LLP.
Read more
